In vivo antimetastatic and immunomodulating activity of phytomix-40

Antimetastatic and immunomodulating activity of Phytomix-40, a new plant preparation containing various adaptogens has been evaluated on the model of Lewis lung carcinoma. Intragastric administration of the drug decreased the intensity of metastatic process by 57% in comparison with the control and improved survival by 43%. This correlated with immunomodulating effect of the drug, which manifested by increased functional activity of T lymphocytes.